The Feasibility of a Novel Intervention for At Risk Mental State
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03160092|
Recruitment Status : Recruiting
First Posted : May 19, 2017
Last Update Posted : May 19, 2017
Young people with At Risk Mental State (ARMS) may have changes in their thoughts and the way they see or hear things, which they might find odd and distressing. They may be feeling tense, worried and low in mood and may not feel like socialising. They may also experience difficulties with eating and sleeping. For many people these symptoms might not last for very long, but for a small number of people, they might last longer and could become worse (health professionals call this psychosis).
Psychological therapy, which involves talking to a therapist, can help to stop these symptoms from getting worse, stopping psychosis. It can also help to make the symptoms better. Cognitive Behavioural Therapy (CBT) is the treatment that is most recommended to help young people with ARMS. But, this is not always available, can take a long time and is quite expensive. Some research has shown that brief therapy with a therapist who is warm and understanding and helps the young person to make sense of their symptoms, may be as helpful as CBT, and is quicker and cheaper.
This study hopes to develop a treatment like this and to offer it to 12 young people, aged between 16 and 25, who are experiencing the symptoms outlined. Participants will be given four treatment sessions, and will be asked to complete some questionnaires. The study aims to see how they find it and whether it seems to help them. It will also ask professionals who work with these young people what they think about the new therapy. This is a feasibility study so the findings will help us to decide whether more research should be done on this treatment and whether it could be offered in the NHS in the future.
|Condition or disease||Intervention/treatment||Phase|
|At Risk Mental State Attenuated Psychotic Symptoms||Other: Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Assessing the Feasibility of a Novel Intervention for Young People With At Risk Mental State and Attenuated Positive Psychotic Symptoms: The Viability of Its Use in the NHS and of a Future Trial|
|Actual Study Start Date :||April 11, 2017|
|Estimated Primary Completion Date :||November 1, 2017|
|Estimated Study Completion Date :||September 1, 2018|
Clinical Participants will receive a 4 session individual intervention, which will be delivered by Assistant Practitioners and Assistant Psychologists (who will have received specific training in the delivering of the intervention).
The intervention will target the participant's attenuated positive psychotic symptoms, which will be referred to as: 'unusual' experiences (unless the participant prefers an alternative).
The therapist will focus on creating a therapeutic relationship in which the participant experiences them as warm, accepting and empathic. The aim is for the participant to feel listened to and understood.
The intervention will focus on taking a normalising and non-catastrophising approach to the individual's unusual experiences. The participants will be provided with psychoeducation to support this aim.
The intervention aims to:
The intervention is not aiming to 'get rid' of the participant's symptoms, but to reduce their distress in response to them, which may result in improved wellbeing and reduced symptoms.
- Comprehensive Assessment of At Risk Mental State (CAARMS) - Change in At Risk Symptoms [ Time Frame: 2 months ]This is a 30 minute semi-structured interview, measuring the intensity, duration and frequency of subthreshold psychotic symptoms
- Clinical Outcomes in Routine Evaluation Outcome Measure (CORE-OM) - Change in psychological wellbeing [ Time Frame: 2 months ]The CORE-OM measures: Psychological wellbeing, functioning, symptoms and risk
- Revised Short Version of the Working Alliance Inventory (WAI-SR) [ Time Frame: 2 months ]Both clinician and client versions of this measure will be used to assess the therapeutic alliance formed for each participant
- Session Rating Scale (SRS) - Completed after each session [ Time Frame: 1 week ]Used to measure the participant's views of each session
- Service User Participant Experience Questionnaire [ Time Frame: 2 months ]Measure of the acceptability of the intervention and the study to the participants receiving the intervention (to inform the feasibility aspect of the study)
- Interventional Therapist Participant Experience Questionnaire [ Time Frame: 2 months ]Measure of the acceptability of the intervention and the study to the clinicians delivering the intervention (to inform the feasibility aspect of the study)
- Youth Team Clinicians Participant Experience Questionnaire [ Time Frame: 2 months ]Measure of the acceptability of the intervention and the study to clinicians working in NHS Youth Teams (to inform the feasibility aspect of the study)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03160092
|Central Norfolk Youth Team, 80 St Stephens Road||Recruiting|
|Norwich, Norfolk, United Kingdom, NR1 3RE|
|Contact: Emma Burton, MSc 00000000000 email@example.com|